Airway management in patients with COVID-19: an updated guide for clinicians in the emergency department : Reviews and Research in Medical Microbiology

Secondary Logo

Journal Logo


Airway management in patients with COVID-19: an updated guide for clinicians in the emergency department

Erenler, Ali Kemala; Komut, Sevala; Çapraz, Mustafab; Baydin, Ahmetc

Author Information
Reviews and Research in Medical Microbiology 33(4):p 248-252, October 2022. | DOI: 10.1097/MRM.0000000000000308
  • Free



The coronavirus disease, also known as Coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 virus has changed the characteristics of many methods used by healthcare providers. These modifications aimed to provide safety and reduce the risk of virus transmission. Some of the recommendations to reduce the risk of aerosol transmission during the intubation are usage of personal protective equipment (PPE) and video laryngoscopy (VL). After satisfactory preoxygenation, along with sedation and paralysis of the patient, modified rapid sequence induction is the recommended technique. Intubation timing and period should be arranged well in order to minimize aerosol spread. During intubation, barrier devices, such as screens and intubation boxes should be considered. Patient coughing during intubation can generate aerosols and should be avoided. Gentle airway manipulation is assured. It is prudent to use VL rather than direct laryngoscopy for intubation because VL increases the distance between the healthcare worker's face and the patient's face, which may minimize the risk of contamination. In this narrative review, we aimed to focus on protective measures and modifications occurred during COVID-19 pandemic.


Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which causes COVID-19, is a singlestranded ribonucleic acid-encapsulated coronavirus and is highly contagious. Transmission is thought to be predominantly by droplet spread by air, and direct contact with the patient or contaminated surfaces [1]. The pandemic has inevitably caused some modifications in common critical procedures in order to reduce viral spread [2]. When performing airway management by endotracheal intubation (ETI), tracheostomy, noninva- sive ventilation (NIV) and, mask ventilation physicians must be careful and follow some safety rules in patients with COVID-19 [3,4].

The staff in the emergency department (ED), particularly, must maintain a high index of suspicion when evaluating all patients, but especially those with COVID-19 symptoms (fever, cough, dyspnea, or signs of a respiratory illness). Although the Centers for Disease Control and Prevention (CDC) developed a real-time reverse transcription-polymerase chain reaction test to detect SARS-CoV-2 [5], the situation still remains risky for false-negative results and delays in test results.

Effective airway management has a great significance to improve respiratory support, reduce complications, and promote rehabilitation [6]. However, patient-oriented approach has to shift to an approach focusing on providers’ safety [7]. In this review, we aimed to focus on modifications in ETI in patients with COVID-19 and underline the importance of staff security during airway interventions.

Materials and methods

This narrative review was conducted by entering the terms ‘airway management’, ‘ETI’, ‘COVID-19’ and ‘coronavirus’ into scientific database; Pubmed©.

One of the reviewers with an experience in database searches designed the search strategy, which was subsequently revised by other reviewers. With consideration to the date of the earliest confirmed reports of COVID-19, the searches were limited to articles published in 2019 and 2020.

Articles are written in other languages than English were excluded from the study. Also, those without full-texts or explanatory abstracts were excluded.

Protective measures prior to intubation

The current World Health Organization and CDC guidance recommends clear communication of the staff, minimising personnel in the room during the procedure, appropriate use of personal protective clothing (PPE) and avoidance of procedures that generate high amounts of aerosols for the protection of personnel in the management of patients with confirmed or suspected COVID-19 [8]. Also, clinicians must be careful for inappropriate use of equipment since the equipment is limited [9]. Protection against aerosolization begins prior to patient enters to the hospital. EDs in most countries have a separate room or area with a portal to outside for COVID-19 patients. These rooms or areas are often located near the ambulance entrance. When a COVID- 19 patient arrives, healthcare providers accompany the patient so that the patient does not travel through the ED avoiding contamination of the clean areas [10].

In this separate area, a tent may be constructed for intubation procedure. It may provide a barrier if the patients coughs or gags. Transparent plastic bags draped over the patient's head to chest may be used for his purpose [11]. A similar protection method, aerosol box, was previously described. It consisted of a transparent plastic shield covering patient's head. It also had two circular ports for the healthcare provider to insert the hands during the intubation [12]. Fang et al. developed a novel, low-cost, easy-to-make protection tent with two components inspired by an umbrella and a raincoat to provide a protective barrier between clinicians and the patient, containing possible aerosol during intubation [13]. However, also some obscurities about the device were reported. Following the removal of the box, the particles would still have the potential to spread and the circular ports could give damage to the protective clothes. Additionally, the box may not fit all the patients and intubation performers. The box may also block the manipulation of ancillary devices such as bougie. These factors may have a bad influence on the success of intubation [14]. PPE in invasive procedures during pandemic is well described in the literature. Even though the role of particles in virus spread is still unclear, a surgical mask, eye protection (goggles or procedure mask with face-shield), an Association for the Advancement of Medical Instrumentation level-2 gown, and gloves that overlap the gown sleeve enough to prevent wrist exposure during movement are recommended [15,16]. An extra protection can be achieved by wearing double gloves for ETI [17]. Antifog measures should be taken for fogging of googles and/or eyewear when using PPE during ETI. It was reported that training and practising PPE use before patient management is essential for staff and patient safety [1].

Into the intubation room, only healthcare providers directly involved in the intubation procedure should enter. Size of the endotracheal tube (ETT) is generally 7.5 mm for females and size 8.0 mm for males. Equipment involving a supraglottic airway device (e.g., laryngeal mask airway or i- gel), gum-elastic bougie, and Magill forceps should be ready in the room. Protective laryngeal reflexes are lost by induction medications. Therefore, suction should be readily connected and be easily accessible to prevent aspiration. Intubation must be terminated rapidly in order to minimize aerosol spread. During intubation, barrier devices, such as screens and intubation boxes should be considered. A plastic sheet can be used if a screen and intubation box are not available [18].

Before leaving the patient's room, gloves may be cleaned with alcohol-based hand sanitiser, gown should be pulled down and teared, the gown should be rolled inside out away from the body, hands should be cleaned with alcohol-based hand sanitiser. Then, the face-shield must be removed by touching the bands, without touching the dirty front surface. Finally, the hands should again be cleaned with alcohol-based hand sanitiser [5].

Endotracheal intubation in COVID-19 patients

COVID-19 may cause airway oedema and laryngitis [19]. Management of airway in COVID-19 patients begins with noninvasive procedures. High-flow nasal cannula (HFNC) is recommended in these patients. After confirmation of upper respiratory system patency, the proper size of the nasal cannula must be selected. An initial flow of 60 L/min and 37°C should be given immediately for patients with obvious respiratory distress or weak cough ability. The aim for oxygen saturation must be above 95% in order to prevent hypoxia and hypoxemia [20]. High-flow nasal oxygenation in critically ill patients not only provides a decrease in intubation time it also causes a less frequent incidence of desaturation during the procedure [21]. However, Cook et al. recommend to avoid high-flow nasal oxygen (HFNO) in a situation of mass illness and mass mechanical ventilation. It may delay ETI in those for whom treatment escalation is appropriate. Additionally, the very high oxygen usage depletes oxygen stores which will probably be required during the pandemic [1]. It was reported that HFNO is not associated with increase in air or surface contamination in a study with patients with bacterial pneumonia [22].

Bilevel positive airway pressure (BiPAP) with a 2-tube system and viral filter, or 100% FiO2 nonrebreather mask may also be used for a proper oxygenation [5].

During HFNC procedure, the patient should wear a surgical mask [20]. It must be kept in mind that Hudson and Venturi masks, nasal cannula and helmets, carry a lower risk of transmission when compared with high- flow nasal oxygen and NIV with facemasks or hoods [23]. For preoxygenation, a 100% nonbreather mask for 3–5 min is used. Bag mask ventilation should be administered when necessary since it increases the risk for crossinfection. NIV should not be chosen as a preoxygenation method but if the patient is already on NIV, it should be continued [18].

Target oxygen saturation in preoxygenation should be 90–92%. Anything applied to the face or trachea such as mask or tube must have a viral filter. It is reasonable not to perform intubation on an awake patient. To ensure patient and provider safety, the procedure may be prolonged. Anytime the bag-valve-mask is squeezed, the risk of aerosolization increases [7]. Avoiding HFNO, establishing conscious sedation with remifentanil before commencing airway topicalisation and avoiding transtracheal local anaesthetic infiltration are also measures that must be taken during intubation [24]. In another study, accordingly, it was reported that the use of HFNO therapies or NIV has the potential to spread the virus, so they were not recommended. In the disease progression, it is more reasonable to intubate the patient with COVID-19 to intubate in the early stage [25]. Preoxygenation should be optimised and bag mask ventilation should be avoided. If manual bagging is mandatory, a gentle ventilation via a supraglottic device instead of bag mask ventilation is suggested [26].

Rapid sequence induction (RSI) is the gold standard in patients with COVID-19 [26,27]. RSI combined with video laryngoscopy (VL) is even highly recommended [28]. Following preoxygenation, modified RSI should be preferred for anaesthesia induction. For patients with anxiety, midazolam 1–2 mg may be administered. Also, lidocaine, 1.5 mg/kg or more, may be useful for suppressing coughing during intubation. In induction, etomidate for unstable patients and propofol for stable patients are recommended [29]. Patients with COVID-19 must be under full neuromuscular blockade when intubation is needed [30].

In RSI medication, etomidate (0.2–0.3 mg/kg) can be used in hemodynamically unstable patients or propofol can be used as induction in hemodynamically stable patients. Short-acting opioids such as fentanyl may induce coughing. Other induction agents include ketamine and methohexital. Muscle relaxation is achieved by either rocuronium (1.2 mg/kg) or succinylcholine (1.0–1.5 mg/kg) [18]. The reason for why rocuronium is preferred over suxamethonium is its longer half-life and its protective properties from coughing and vomiting. Chang et al. also recommend rocuronium with an IV dose of 1–2 mg/kg at a similar onset time to suxamethonium [26].

Midazolam has fewer cardiovascular side effects and it is a strong amnesic agent. In a study with 202 COVID-19 patients, a combination of etomidate or ketamine with low-dose midazolam was recommended. Prophylactic cardiovascular-stimulating agents must be ready to use at the time of ETI to minimise hypotension. Due to its rapid onset of action, Rocuronium, instead of succinylcholine, was also recommended as a neuromuscular blocking agent. When compared to succinylcholine, rocuronium also reduces coughing in case the intubation is prolonged [28]. Due to the nature of coronaviruses, cough is one of the major ways of human-to-human spread. In the airway management interventions, any airway instrumentation can exacerbate coughing. Fentanyl may cause coughing following premedication with fentanyl (given prior to induction of anaesthesia) and can be prevented by a single intravenous dose of lidocaine. Lidocaine is proposed at the beginning and the end of any procedure requiring intubation and/or extubation in patients with COVID- 19 [31].

Respiratory distress develops in about 14% of the patients with COVID-19 [32]. In another study, the rate of Acute respiratory distress syndrome (ARDS) was found to be 20% in hospitalized patients and 61% in patients admitted to the intensive care unit (ICU) [33]. According to Benjamin etal., use of The King LT(S)-D laryngeal tube (King Systems, Noblesville, IN) extraglottic device, used in combination with administration of a highdose paralytic medication also reduces coughing [34]. The use of a bougie during intubation may cause tracheal trauma and worsen the respiratory condition. When glottis is not visible, careful use of bougie is mandatory [35]. Making the decision to whether to proceed with intubation or performing invasive ventilation in patients with COVID-19 who suffer acute hypoxemic respiratory failure remains as a challenging issue. The Chinese Society of Anesthesiology Task Force on Airway Management recommends recommendation to proceed with ETI for patients showing no improvement in respiratory distress, tachypnea (respiratory rate greater than 30 per minute), and poor oxygenation (Pao2 to Fio2 ratio less than 150 mmHg) after 2-h high flow oxygen therapy or NIV [36]. With holding intubation has the risk of cross-infection in patients and also carries a risk to healthcare providers [37].

It is also recommended that intubation and ventilation should be performed by emergency physicians and anaesthesiologists [38]. In a study in the USA by Aziz et al., it was reported that a team of anesthesiologists was constituted for intubation [25]. Since it is essential to minimize the distance between the patient and the healthcare provider, VL rather than direct laryngoscopy must be preferred in patients with COVID-19 [29]. In a study by Schumacher et al., the shortest time intubation was achieved by VL [39]. In case it is inevitable to perform the intubation with direct laryngoscopy, it should be perfor med as soon as possible by the most experienced team member. Additionally, confirmation of the place of the tube and the quality of the CPR must be done by exhaust carbon dioxide detectors [40]. In order to minimize aerosol spread, besides use of VL, usage of personal protective equipment (PPE) is highly recommended. When possible, a closed system with the HEPA filter already attached to the ETT via either the HEPA-ETT (‘HE’) or ‘Swivel-HEPA-ETT (SHE)- bougie’ methods may help to prevent healthcare providers from droplets originating from the larynx and trachea. Also, the ventilator may be attached to the HEPA filter following intubation [41–43]. It was reported that, early after the intubation, patients who were positioned prone developed a lower rate of pneumothorax following ARDS [44].

As mentioned above, rapid-sequence fibreoptic bronchoscopic ETI in COVID-19 pneumonia patients reduces the risk of coughing and subsequently viral spread when compared to laryngoscopy. Besides, neuromuscular blocking agents may also eliminate the risk of coughing when intubation with laryngoscopy is inevitable [21]. When intubation with fiberoptic laryngoscope is performed, the controller should be held vertically above the airway in order to maintain the distance between the perfor mer and the patient. If the device is stabilised with the hand over the nose or mouthdareas, virus may transmit easily [22]. It is also known that fibreoptic intubation needs skill and is timeconsuming so that after two failed attempts, the use of fibreoptic intubation only through a second-generation intubating supraglottic airway device is suggested [45].

The pattern of ventilation should be monitored by a continuous waveform capnography monitoring device since a correct waveform accurately reflects correct ETT placement. It might give clues on the adequacy of the seal when using supraglottic devices [26].


Airway management of patients with COVID-19 should be performed in a separate area near the ambulance entrance. In this area, the number of staff must be minimised in order to reduce virus spread. The team should be constituted of Emergency physicians or anaesthesists, or a mixture of these specialities. A tent covering the head and the chest of the patient may be constructed for intubation. The most skilled and experienced member of the team must perform the procedure as soon as possible. High-flow nasal oxygenation in critically ill patients not only provides a decrease in intubation time it also causes a less frequent incidence of desaturation during the procedure however, at the other hand, HFNO may cause consumption of limited sources. Anything applied to the face or trachea such as mask or tube must have a viral filter. RSI combined with VL is even highly recommended. In RSI, rocuronium should be the choice as an agent.


Authors declare no funding.

Author contributions: A.K.E. contributed in designing, writing, literature review, English editing and supervision. S.K. contributed in literature review. M.Ç. contributed in literature review. A.B. contributed in literature review, English editing and critical review.

Conflicts of interest

There are no conflicts of interest.


1. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia 2020; 75:785–799.
2. Broderick D, Kyzas P, Sanders K, Sawyerr A, Katre C, Vassiliou L. Surgical tracheostomies in Covid-19 patients: important considerations and the ‘5Ts’ of safety. Br JOral Maxillofac Surg 2020; 58:585–589.
3. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020; 323:1843–1844.
4. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. N Engl J Med 2020; 382:1564–1567.
5. Giwa AL, Desai A, Duca A. Novel 2019 coronavirus SARS-CoV- 2 (COVID-19): an overview for emergency clinicians. Pediatr Emerg Med Pract 2020; 17:1–24.
6. Xu W, Zhou B, Han DM. Airway management of COVID-19 patients with severe pneumonia. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 55:309–312.
7. Kovacs G, Sowers N, Campbell S, French J, Atkinson P. Just the facts: airway management during the coronavirus disease 2019 (COVID-19) pandemic. CJEM 2020; 22:440–444.
8. Peng PWH, Ho PL, Hota SS. Outbreak of a new coronavirus: what anaesthetists should know. Br J Anaesth 2020; 124:497–501.
9. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review. Anaesthesia 2020; 75:920–927.
10. Sampson CS. Adaption of the emergency department decontamination room for airway management during COVID-19. Am J Emerg Med 2020; 38:1531–1532.
11. Au Yong PS, Chen X. Reducing droplet spread during airway manipulation: lessons from the COVID-19 pandemic in Singapore. Br J Anaesth 2020; 125:e176–e178.
12. Everington K. Taiwanese doctor invents device to protect US doctors against coronavirus. Taiwan News. 7 April 2020).
13. Fang PH, Lin YY, Lin CH. A protection tent for airway management in patients with COVID-19 infection. Ann Emerg Med 2020; 75:787–788.
14. Kearsley R. Intubation boxes for managing the airway in patients with COVID-19. Anaesthesia 2020; 75:969.
15. Verbeek JH, Rajamaki B, Ijaz S, Ijaz S, Sauni R, Toomey E, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev 2019; 7:CD01162.
16. Lockhart SL, Duggan LV, Wax RS, Saad S, Grocott HP. Personal protective equipment (PPE) for both anesthesiologists and other airway managers: principles and practice during the COVID-19 pandemic. Can J Anaesth 2020; 67:1005–1015.
17. Casanova LM, Rutala WA, Weber DJ, Sobsey MD. Effect of single- versus double gloving on virus transfer to healthcare workers’ skin and clothing during removal of personal protective equipment. Am J Infect Control 2012; 40:369–374.
18. Chahar P, Dugar S, Marciniak D. Airway management considerations in patients with COVID-19. Cleve Clin J Med 2020; doi: 10.3949/ccjm.87a.ccc033. [Epub ahead of print].
19. McGrath BA, Wallace S, Goswamy J. Laryngeal oedema associated with COVID-19 complicating airway management. Anaesthesia 2020; 75:972.
20. He G, Han Y, Fang Q, Zhou J, Shen J, Li T, et al. Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020; 49:232–239.
21. Wu CN, Xia LZ, Li KH, Ma WH, Yu DN, Qu B, et al. High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial. Br J Anaesth 2020; 125:e166–e168.
22. Lyons C. Fibreoptic tracheal intubation in COVID-19: not so fast. Br J Anaesth 2020; 125:e170–e171.
23. Li Y, Huang X, Yu IT, Wong TW, Qian H. Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong. Indoor Air 2005; 15:83–95.
24. Ahmad I, Wade S, Langdon A, Chamarette H, Walsh M, Surda P. Awake tracheal intubation in a suspected COVID-19 patient with critical airway obstruction. Anaesth Rep 2020; 8:28–31.
25. Aziz MF. The COVID-19 intubation experience in Wuhan. Br J Anaesth 2020; 125:e25–e27.
26. Cheung JC, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med 2020; 8:e19.
27. Rassekh CH, Jenks CM, Ochroch EA, Douglas JE, O’Malley BW Jr, Weinstein GS. Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario. Head Neck 2020; 42:1273–1277.
28. Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Collaborators. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Br J Anaesth 2020; 125:e28–e37.
29. Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience. Anesthesiology 2020; 132:1317–1332.
30. Dalli J, Khan MF, Marsh B, Nolan K, Cahill RA. Evaluating intubation boxes for airway management. Br J Anaesth 2020; 125:e293–e295.
31. Aminnejad R, Salimi A, Saeidi M. Lidocaine during intubation and extubation in patients with coronavirus disease (COVID- 19). Can J Anaesth 2020; 67:759.
32. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708–1720.
33. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323:1061–1069.
34. Sandefur BJ, Driver BE, Brown CA 3rd, Reardon RF. Definitive airway management of patients with a King Laryngeal Tube™ in place in the COVID-19 pandemic. West J Emerg Med 2020; 21:542–545.
35. Abou-Arab O, Huette P, Berna P, Mahjoub Y. Tracheal trauma after difficult airway management in morbidly obese patients with COVID-19. Br J Anaesth 2020; 125:e168–e170.
36. Zuo MZ, Huang YG, Ma WH, Xue ZG, Zhang JQ, Gong YH, et al. Chinese Society of Anesthesiology Task Force on Airway Management: Expert recommendations for tracheal intubation in critically ill patients with noval coronavirus disease 2019. Chin Med Sci J 2020; 3105105-108.
37. McCracken J. Should noninvasiveventilation beconsidered a high- risk procedure during an epidemic? CMAJ 2009; 181:663–664.
38. Lin LW, Hung TY. Swivel-HEPA-ETT (SHE) bougie and HEPA- ETT (HE) methods for safe intubation while managing patients with COVID-19. Emerg Med J 2020; 37:256–257.
39. Schumacher J, Arlidge J, Dudley D, Sicinski M, Ahmad I. The impact of respiratory protective equipment on difficult airway management: a randomised, crossover, simulation study. Anaesthesia 2020; 75:1301–1306.
40. Szarpak L, Drozd A, Smereka J. Airway management and ventilation principles in COVID-19 patients. J Clin Anesth 2020; 65:109877.
41. Judson SD, Munster VJ. Nosocomial transmission of emerging viruses via Aerosol-Generating medical procedures. Viruses 2019; 11:940.
42. Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis 2019; 19:101.
43. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7:e35797.
44. Alhazzani W, Møller Mh, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46:854–887.
45. Sorbello M, Di Giacinto I, Corso RM, Cataldo R. Societa Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Management Research Group. Prevention is better than the cure, but the cure cannot be worse than the disease: fibreoptic tracheal intubation in COVID-19 patients. Br J Anaesth 2020; 125:e187–e188.

airway management; COVID-19; endotracheal intubation; personal protective clothing

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.